series-c-plus
Stage
1
Investors
About
Sitryx Therapeutics is a clinical-stage biopharmaceutical company developing therapies that modulate immunometabolism to treat autoimmune and inflammatory diseases.
Explore Sitryx Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.